In Brief
This article was originally published in The Rose Sheet
Executive Summary
FDA warns Vienna Beauty Products for microbial contamination. Beiersforf posts solid first half results thanks to sales outside of Europe and strength of NIVEA brand. More.
You may also be interested in...
FDA Enforcement Priorities: Eye Products, Dual Drug/Cosmetic Firms
When FDA inspects a facility producing both drugs and cosmetics, the manufacturer should be using one standard and that’s the drug standard, says Karyn Campbell, director of the investigations branch at FDA’s Philadelphia District Office.
Activist Investor May Urge P&G To Lose Non-Core Brands, McDonald
Changes may be ahead for Procter & Gamble following William Ackman and Pershing Square Capital Management’s investment in the Cincinnati-based consumer-goods giant. Analysts suggest the activist investor may push to replace CEO Bob McDonald and divest non-core brands.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.